Answers are grounded in this paper and cite their sources.
Observational analysis assessed metabolic indicators like resting energy expenditure in CeH patients, suggesting the FT3/FT4 ratio could guide treatment strategies.
Background/Introduction Central hypothyroidism (CeH) is a rare disease characterized by low FT4 levels and an inappropriately normal or low TSH. Indirect calorimetry (IC) measures resting energy expenditure (REE, as % of predicted), an indicator of metabolism that is typically reduced in hypothyroidism. Purpose To assess the role of IC in identifying metabolic alterations associated with CeH and detecting insufficient/inadequate therapy. Methods We performed IC on 34 patients with CeH of different etiologies (genetic, hypothalamic/pituitary lesion, idiopathic) under various conditions: on adequate therapy (FT4 in the upper half of the reference range, TSH <0.5 mU/L), off therapy, and on suboptimal therapy. Results 21 patients underwent two measurements: on adequate therapy and suboptimal/off therapy (inadequate); the other 13 had only the latter evaluation. REE inversely correlated with total cholesterol levels (P=0.0032) and the FT3/FT4 ratio. Notably, the FT3/FT4 ratio was lower in adequately treated patients compared to those in hypothyroid states (P=0.05), although this difference was less marked when considering only the 21 patients with paired measurements. Among the subgroup assessed before and after therapy adjustment, 52% showed increased REE after dosage escalation, one patient showed no change, while unexpectedly, 42% showed a decrease despite an increased LT4 dosage. Mann-Whitney test indicated that a lower FT3/FT4 ratio predicts REE improvement upon reaching therapeutic targets (P=0.01). Moreover, multivariate regression confirmed a trend toward a negative correlation between REE improvement and a low FT3/FT4 ratio (P=0.06). Conclusion(s) The significant correlation between REE and cholesterol levels confirms the utility of IC in metabolic assessment of CeH patients. Patients with a higher baseline FT3/FT4 ratio showed a poor metabolic response to LT4 dosage increase aimed at achieving target FT4 levels. The FT3/FT4 ratio may reflect a compensatory response to pre-existing, thyroid hormone–independent metabolic disturbances; if confirmed, it could help identify patient subgroups suitable for alternative therapeutic strategies (e.g., combined therapy with liothyronine). Further analyses are needed to determine whether the FT3/FT4 ratio is a cause or a consequence of altered metabolism in these patients, and to explore its underlying pathogenic mechanisms.
No takes yet. Share an insight, caveat, or question.
Donne et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: